Stay updated on MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Sign up to get notified when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.
Latest updates to the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page
- CheckyesterdayChange DetectedMinor system revision from v3.3.3 to v3.3.4; there is no visible change to the page content or study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a unified Locations section listing all study sites by state, and removed the prior state-specific Locations headings. This centralizes site information and clarifies where the study is taking place.SummaryDifference1%
- Check51 days agoChange DetectedRevision: v3.3.2 has been added, replacing the previous v3.2.0.SummaryDifference0.0%
- Check58 days agoChange DetectedA notice about government funding and potential updates on NIH operations was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check72 days agoChange DetectedStudy NCT04795713 (MT-6402) is terminated by the sponsor; enrollment reached 64 and completion date is 2024-10-31.SummaryDifference0.3%
- Check101 days agoChange DetectedMajor update adds a funding/status notice and marks revision to v3.2.0; a specific resource title was removed (v3.1.0).SummaryDifference2%
Stay in the know with updates to MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.